M Østergaard Selected Research

M Østergaard Research Topics

Disease

31	Rheumatoid Arthritis 01/2022 - 11/2001
8	Necrosis 05/2020 - 08/2005
7	Synovitis 01/2021 - 10/2005
5	Inflammation (Inflammations) 01/2022 - 10/2009
4	Pain (Aches) 05/2020 - 01/2015
3	Fatigue 05/2020 - 01/2015
3	Axial Spondyloarthritis 05/2020 - 07/2016
2	Osteitis 01/2022 - 09/2017
2	Ankylosing Spondylitis 05/2019 - 07/2017
2	Tenosynovitis 09/2017 - 10/2009
2	Rheumatic Diseases (Rheumatism) 09/2016 - 07/2009
2	Psoriatic Arthritis 01/2014 - 07/2013
1	Osteoarthritis 01/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 05/2020
1	Arthritis (Polyarthritis) 12/2017
1	Fibrosis (Cirrhosis) 12/2017
1	Back Pain (Backache) 07/2016
1	Joint Diseases (Joint Disease) 01/2015
1	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2011
1	Hypertension (High Blood Pressure) 06/2008
1	Ulcerative Colitis 01/2007
1	Isochromosomes 01/2002

Drug/Important Bio-Agent (IBA)

9	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 10/2005
7	Adalimumab (Humira)FDA Link 07/2017 - 10/2009
5	C-Reactive ProteinIBA 09/2017 - 07/2013
4	Biological ProductsIBA 01/2022 - 08/2005
4	GlucocorticoidsIBA 01/2019 - 06/2008
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2013
3	ametantrone (HAQ)IBA 01/2022 - 10/2015
3	Anti-Citrullinated Protein AntibodiesIBA 01/2019 - 01/2015
2	Galectin 3 (LGALS3)IBA 01/2022 - 12/2017
2	Antirheumatic Agents (DMARD)IBA 01/2022 - 06/2008
2	GadoliniumIBA 01/2021 - 03/2012
2	Certolizumab Pegol FDA Link 03/2020 - 06/2015
2	Vitamin D FDA LinkGeneric 01/2020 - 01/2017
2	cyclic citrullinated peptideIBA 01/2019 - 01/2015
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2017 - 06/2014
2	Betamethasone (Celestone)FDA Link 09/2017 - 06/2014
2	AntigensIBA 07/2017 - 07/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009 - 07/2008
1	Protons (Proton)IBA 01/2021
1	Hypnotics and Sedatives (Sedatives)IBA 05/2020
1	golimumab FDA Link 05/2020
1	Tumor Necrosis Factor InhibitorsIBA 05/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	procollagen Type III-N-terminal peptide (PIIP)IBA 12/2017
1	3-benzoyl dopamine (MBDA)IBA 09/2017
1	Immunoglobulin G (IgG)IBA 07/2017
1	Immunoglobulin A (IgA)IBA 07/2017
1	Triamcinolone (Aristocort)FDA Link 04/2017
1	triamcinolone hexacetonide (Aristospan)FDA Link 09/2016
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 07/2016
1	calinIBA 07/2016
1	Circulating MicroRNAIBA 04/2016
1	Interleukin-23 (Interleukin 23)IBA 01/2015
1	AntibodiesIBA 01/2015
1	EpitopesIBA 01/2015
1	InterleukinsIBA 01/2015
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 06/2014
1	CC ChemokinesIBA 01/2014
1	CCR7 ReceptorsIBA 01/2014
1	LigandsIBA 01/2014
1	Complementary DNA (cDNA)IBA 07/2011
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2009
1	SteroidsIBA 07/2009
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2008
1	CreatinineIBA 06/2008
1	XenobioticsIBA 01/2007
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2007
1	Pharmaceutical PreparationsIBA 10/2005
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2005
1	DNA (Deoxyribonucleic Acid)IBA 01/2002
1	Satellite DNA (Satellite DNAs)IBA 01/2002
1	Gadolinium DTPA (Magnevist)FDA Link 11/2001

Therapy/Procedure

9	Therapeutics 05/2020 - 06/2008
1	Aftercare (After-Treatment) 01/2022
1	Perioperative Period 07/2009
1	Injections 06/2008